TriGenex

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

Bifidobacterium infantis, Quantity: 3.2 billion CFU; Bifidobacterium longum, Quantity: 4.1 billion CFU; Bifidobacterium breve, Quantity: 4 billion CFU

Disponible des:

Biomedica Nutraceuticals Pty Ltd

Designació comuna internacional (DCI):

Bifidobacterium breve,Bifidobacterium infantis,Bifidobacterium longum

formulario farmacéutico:

Capsule, hard

Composición:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; tricalcium phosphate; tapioca starch; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum

Vía de administración:

Oral

indicaciones terapéuticas:

Maintain/support general health and wellbeing ; Maintain/support healthy digestive system function ; Maintain/support healthy digestion ; Maintain/support digestive system health ; Maintain/support intestinal good/beneficial/friendly flora ; Helps restore good/beneficial/friendly intestinal/gut/bowel flora ; Maintain/support immune system health ; Maintain/support healthy immune system function

Resumen del producto:

Visual Identification: ;

Estat d'Autorització:

Licence status A

Data d'autorització:

2017-06-30